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Hepatitis E virus (HEV) genotype 3 is endemic in the United Kingdom but the complete sequence of HEV, generated directly
from a clinical sample, is lacking. We report a near full-length genome sequence of genotype 3 HEV from the serum of a patient
with acute hepatitis.
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Hepatitis E virus (HEV) is the most common cause of acuteviral hepatitis in the United Kingdom. The frequency of de-
tection of acute HEV infection was reported to be 31-, 9-, and
12-times higher than that of hepatitis A, B, and C, respectively (1).
About half of acute hepatitis E cases in England and Wales were
reported to be autochthonous infections (2–5). At present, there is
only one complete genome sequence of human HEV in GenBank
from the United Kingdom, cell-adapted Kernow-C1 strain (6). A
near full-length genome sequence of HEV was obtained from an
anonymized residual serum sample from a patient with acute hep-
atitis from England, strain SLC-4.
RNA was extracted from 200-l serum using the GenElute
Mammalian Total RNA miniprep kit (Sigma Aldrich), and then
treated with DNase (Roche). cDNA was synthesized using Super-
Script III reverse transcriptase (Thermo Fisher). The viral genome
was amplified in four segments using a nested PCR approach with
a touchdown cycling protocol as previously described (7). Se-
quences at the extremity of the viral genome were determined by
using 5= and 3= rapid amplification of cDNA ends (RACE) (Life
Technologies). Sanger sequencing was performed using 16 prim-
ers covering the HEV genome (7). Overlapping sequences were
assembled by the Vector NTI Express Designer software (Thermo
Fisher Scientific).
A sequence of 7,229 bp in length with GC content of 55% was
generated from SLC-4. While 5= RACE provided some sequences
of the 5= end of the HEV genome, due to the limited volume of
clinical sample, we were unable to determine the 25 nucleotides
of the 5= untranslated region (UTR) and the first 18 nucleotides of
open reading frame 1 (ORF-1). The genomic organization of
SLC-4 was similar to those of other genotype 3 HEVs: ORF-1 (up
to nucleotide [nt] 5,094), ORF-2 (nt 5,129 to 7,114), ORF-3 (nt
5,091 to 5,459), and 3= UTR (nt 7,115 to 7,229). The nucleotide
similarity of 90% and 86% was found between SLC-4 and se-
quences recovered from wild boars from Germany (FJ705359)
and Mongolia (AB290312), respectively. The closest HEV genome
(89%) recovered from a human was from a chronically infected
kidney transplant recipient in southeastern France (KJ701409).
Eighty-four percent homology was found between SLC-4 and
Kernow-C1.
About 15% of pig meat consumed in the United Kingdom is
imported (8), giving rise to the possibility of an enormous
genomic diversity among locally prevalent strains. Homology be-
tween SLC-4 and other human and pig strains shows the extent of
their genetic relatedness. However, due to the lack of genomic
data, we are unable to examine the genetic relatedness of SLC-4
and strains prevalent in the United Kingdom. British epidemio-
logical studies, quoted above, are based on sequencing data from a
304-nt segment of ORF-2 (2, 3), providing only a limited amount
of information about the magnitude and nature of genomic diver-
sity among HEV strains circulating in the United Kingdom. A
comprehensive genetic analysis of HEV strains from the United
Kingdom human and animal reservoirs is critical to gain a better
knowledge of the diversity and epidemiology of this virus.
Accession number(s).The sequence is available in GenBank
under accession no. KX462160.
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